1 hour ago
3
David Jagielski, CPA, The Motley Fool
Sat, May 2, 2026 astatine 11:50 AM CDT 4 min read
The U.S. authorities precocious rescheduled aesculapian marijuana from a Schedule I substance to Schedule III, which is large quality for the manufacture and marks a milestone. It's an acknowledgment that determination are valid aesculapian uses for marijuana, and galore cannabis companies successful the U.S. volition payment arsenic a effect of that.
Tilray Brands (NASDAQ: TLRY) is simply a Canadian-based cannabis producer, and portion determination whitethorn beryllium optimism astir it perchance entering the U.S. marijuana market, here's wherefore you shouldn't number connected that happening anytime soon.
Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »
Rescheduling is not legalization
The astir important happening for cannabis investors to retrieve is that rescheduling marijuana is not the aforesaid happening arsenic legalization. With rescheduling, it'll beryllium easier to probe marijuana successful the U.S., but by nary means is the borderline unfastened for Canadian producers to determination cannabis products south. Marijuana remains a controlled substance and is federally illegal. While rescheduling has taken spot for medically licensed marijuana, recreational products haven't been rescheduled yet, and portion it whitethorn look that the manufacture is moving toward legalization, determination is thing to suggest that volition hap anytime soon.
Tilray Brands, however, jumped astatine the accidental to punctual investors that it's "positioned for U.S. expansion" successful a caller property release, successful which it called the determination "a defining inflection point." While Tilray is decidedly successful a bully presumption to instrumentality vantage if the accidental arises to participate the U.S. cookware marketplace (whether for recreational oregon medicinal products), that doesn't mean a large determination similar that is coming soon.
Even if the Trump medication moved guardant with legalization efforts oregon broader reform, the process unsocial could instrumentality years. Investors shouldn't hide that it was backmost successful October 2022 erstwhile then-President Joe Biden archetypal asked the U.S. Department of Health and Human Services and Drug Enforcement Administration to reappraisal marijuana scheduling. Government betterment tin instrumentality a sizeable magnitude of time.
Investing based connected hopes of authorities betterment hasn't played retired good for investors
For years, cannabis investors person been holding onto cookware stocks successful the hopes that legalization successful the U.S. mightiness beryllium coming soon. In the end, it has simply resulted successful immoderate important losses. The past clip Tilray Brands' banal generated a affirmative yearly instrumentality for investors was backmost successful 2018, erstwhile it soared 215% -- erstwhile Canada legalized marijuana. It's been downhill ever since, successful what's been an epic illustration of "buy the rumor, merchantability the news."
English (CA) · 
English (US) · 
Spanish (MX) ·